An Integrated Ligand- and Structure-Based Virtual Screening and Experimental Strategy for the Prediction of Chemically Diverse GLP-1R Agonists
The glucagon-like peptide-1 receptor (GLP-1R) plays a central role in metabolic regulation and is a major therapeutic target for obesity and diabetes. Peptide agonists, like semaglutide, targeting GLP-1R, remain among the most effective regulators of glucose metabolism and appetite. Nonetheless, recent reports of wei...